HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H van Tinteren Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2020Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study.
1/2020Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry.
10/2019Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III study.
3/2011First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging.
1/2010Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment.
5/2004Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients.
2/2003The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment.
12/2002Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.
8/2001Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
1/2000A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H van Tinteren Research Topics

Disease

12Breast Neoplasms (Breast Cancer)
07/2022 - 03/2000
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2000
9Neoplasms (Cancer)
07/2022 - 05/2000
3Brain Neoplasms (Brain Tumor)
01/2020 - 05/2004
3Disease Progression
05/2019 - 05/2004
3Colorectal Neoplasms (Colorectal Cancer)
09/2017 - 08/2014
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2018
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 05/2019
2Lung Neoplasms (Lung Cancer)
01/2020 - 06/2000
2Neutropenia
12/2014 - 04/2000
2Hand-Foot Syndrome
12/2014 - 03/2014
2Rectal Neoplasms (Rectal Cancer)
10/2014 - 10/2004
2Peritoneal Neoplasms
08/2014 - 06/2004
2Exanthema (Rash)
03/2014 - 05/2004
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2012 - 03/2010
1Peripheral Nervous System Diseases (PNS Diseases)
10/2018
1Melanoma (Melanoma, Malignant)
03/2015
1Carcinoma (Carcinomatosis)
10/2014
1Stomatitis
03/2014
1Fatigue
03/2014
1Frailty
02/2014
1Transitional Cell Carcinoma
03/2010
1Non-Muscle Invasive Bladder Neoplasms
03/2010
1Lymphatic Metastasis
04/2006
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2006
1Hemorrhage
01/2006
1Hypoxia (Hypoxemia)
02/2005
1Wilms Tumor (Wilm's Tumor)
12/2004
1Margins of Excision
10/2004
1Diarrhea
05/2004
1Neoplasm Metastasis (Metastasis)
02/2003
1Iron Deficiencies
12/2001
1Fistula
11/2000

Drug/Important Bio-Agent (IBA)

6Bevacizumab (Avastin)FDA Link
01/2021 - 03/2011
5Paclitaxel (Taxol)FDA LinkGeneric
09/2018 - 01/2000
5Capecitabine (Xeloda)FDA Link
09/2017 - 03/2014
3TamoxifenFDA LinkGeneric
07/2022 - 02/2002
3PlatinumIBA
01/2021 - 03/2006
3AnthracyclinesIBA
10/2018 - 11/2006
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2018 - 05/2002
3Fluorouracil (Carac)FDA LinkGeneric
10/2014 - 05/2002
2Estrogen ReceptorsIBA
07/2022 - 05/2000
2Docetaxel (Taxotere)FDA Link
10/2018 - 04/2000
2Indicators and Reagents (Reagents)IBA
02/2014 - 02/2002
2Alkylating AgentsIBA
07/2011 - 04/2006
2Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2011 - 01/2010
2Deoxyglucose (2 Deoxy D glucose)IBA
03/2011 - 02/2003
2Gefitinib (Iressa)FDA Link
01/2010 - 05/2004
2Epirubicin (Ellence)FDA LinkGeneric
04/2006 - 05/2002
2Carboplatin (JM8)FDA LinkGeneric
04/2006 - 03/2006
2Cyclin D1IBA
02/2002 - 05/2000
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1Taxoids (Taxanes)IBA
10/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018
1N,N- dimethyl- N- hexadecyl- 1- octadecylammonium (DDAC)IBA
10/2018
1Biomarkers (Surrogate Marker)IBA
10/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2017
1dabrafenibIBA
03/2015
1tributyl phosphate (TBP)IBA
03/2015
1VemurafenibIBA
03/2015
11-dodecylpyridoxal (PLD)IBA
03/2014
1liposomal doxorubicin (Doxil)FDA Link
03/2014
1CP 4126IBA
08/2013
1DNA (Deoxyribonucleic Acid)IBA
07/2011
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
07/2011
1FluorineIBA
03/2011
1ErbB Receptors (EGF Receptor)IBA
01/2010
1Tyrosine Kinase InhibitorsIBA
01/2010
1Carcinoembryonic AntigenIBA
01/2010
1Type II DNA Topoisomerases (Topoisomerase II)IBA
11/2006
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
04/2006
1Etoposide (VP 16)FDA LinkGeneric
03/2006
1Hypoxia-Inducible Factor 1IBA
02/2005
1Transcription Factors (Transcription Factor)IBA
02/2005
1N 30IBA
12/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2002
1LigandsIBA
02/2002
1Cyclin AIBA
02/2002
1Ferritins (Ferritin)IBA
12/2001
116-iodo-3-methylhexadecanoic acid (MIHA)IBA
08/2001

Therapy/Procedure

16Drug Therapy (Chemotherapy)
07/2022 - 01/2000
4Radiotherapy
04/2006 - 05/2004
3Therapeutics
01/2021 - 01/2010
3Adjuvant Chemotherapy
01/2021 - 11/2006
3Neoadjuvant Therapy
08/2014 - 05/2002
2Cranial Irradiation
01/2020 - 10/2019
2Hyperthermic Intraperitoneal Chemotherapy
05/2019 - 06/2004
2Cystectomy
01/2012 - 03/2010
2Induction Chemotherapy
02/2003 - 05/2002
1Immunotherapy
01/2020
1Gastrectomy
05/2019
1Laparotomy
05/2019
1Cytoreduction Surgical Procedures
05/2019
1Chemoradiotherapy
10/2014
1Urinary Diversion (Ileal Conduit)
01/2012
1Aftercare (After-Treatment)
03/2010
1Surgical Amputation (Amputations)
08/2006
1Tracheotomy
01/2006
1Adjuvant Radiotherapy
10/2004
1Prostheses and Implants (Prosthesis)
11/2000